Clinical characterization of hemophagocytic lymphohistiocytosis caused by immune checkpoint inhibitors: a review of published cases
Z Xu, H Li, X Yu, J Luo, Z Zhang - Hematology, 2024 - Taylor & Francis
Objective: An association exists between immune checkpoint inhibitors and hemophagocytic
lymphohistiocytosis (HLH). Therefore, the main objective of this study was to collect data on …
lymphohistiocytosis (HLH). Therefore, the main objective of this study was to collect data on …
A case report of hemophagocytic lymphohistiocytosis induced by toripalimab plus chemoradiotherapy in cervical cancer
S Wei, H Chen, X Deng, P Jiang, J Wang - Heliyon, 2024 - cell.com
Background Hemophagocytic lymphohistiocytosis (HLH) is a rare but life-threatening clinical
syndrome characterized by immune hyperactivation. Unlike primary HLH, immune …
syndrome characterized by immune hyperactivation. Unlike primary HLH, immune …